Showing results (71-80 of 130) with videos related to
Sort By:
Pageof 13
Diabetologia|November 9, 2025
Precision medicine in type 2 diabetes: targeting SGLT2 inhibitor treatment for kidney protectionThijs T Jansz, Katherine G Young, Rhian Hopkins, et al.Scientific Reports|June 13, 2020
Type 1 diabetes genetic risk score is discriminative of diabetes in non-Europeans: evidence from a study in IndiaJames W Harrison, Divya Sri Priyanka Tallapragada, Alma Baptist, et al.Diabetic Medicine : a Journal of the British Diabetic Association|April 8, 2019
Persistent C-peptide is associated with reduced hypoglycaemia but not HbA<sub>1c</sub> in adults with longstanding Type 1 diabetes: evidence for lack of intensive treatment in UK clinical practice?S M Marren, S Hammersley, T J McDonald, et al.Diabetes Care|March 29, 2022
The Incidence of Adult-Onset Type 1 Diabetes: A Systematic Review From 32 Countries and RegionsJessica L Harding, Pandora L Wander, Xinge Zhang, et al.Diabetologia|July 17, 2021
DR15-DQ6 remains dominantly protective against type 1 diabetes throughout the first five decades of lifeNicholas J Thomas, John M Dennis, Seth A Sharp, et al.Diabetologia|February 27, 2025
IA-2A positivity increases risk of progression within and across established stages of type 1 diabetesEmily K Sims, David Cuthbertson, Lauric A Ferrat, et al.The Lancet. Primary Care|May 11, 2026
Kidney outcomes with GLP-1 receptor agonists in people with type 2 diabetes already receiving SGLT2 inhibitors: a target trial emulation study using UK primary care dataThijs T Jansz, Andrew P McGovern, Katherine G Young, et al.Diabetes Care|December 9, 2025
Genetic Predictors of Response to Oral Insulin for Type 1 Diabetes PreventionLu You, Hemang M Parikh, Taylor M Triolo, et al.The Journal of Clinical Endocrinology and Metabolism|May 20, 2024
Genetic Associations With C-peptide Levels Before Type 1 Diabetes Diagnosis in At-risk RelativesTaylor M Triolo, Hemang M Parikh, Mustafa Tosur, et al.Diabetes Care|January 19, 2019
Development and Standardization of an Improved Type 1 Diabetes Genetic Risk Score for Use in Newborn Screening and Incident DiagnosisSeth A Sharp, Stephen S Rich, Andrew R Wood, et al.Pageof 13